Using electronic monitoring to improve HIV medication adherence
Feasibility, acceptability, and pilot trial of a real-time electronic adherence monitoring intervention for antiretroviral therapy
['FUNDING_OTHER'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-10759928
This study is testing a new way to help African American men who have sex with men remember to take their HIV medication on time by using a special system that sends reminders and includes support from friends or case managers to keep them motivated.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-10759928 on ClinicalTrials.gov |
What this research studies
This research investigates a new method to help African American men who have sex with men (AAMSM) adhere to their antiretroviral therapy (ART) for HIV. It employs a real-time electronic adherence monitoring system that alerts users when they miss doses and involves social support to encourage adherence. The approach is designed to motivate patients and improve their medication-taking behaviors, ultimately aiming to suppress the viral load of HIV. The study will also explore how social support persons and case managers perceive and respond to notifications about missed doses.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American men who have sex with men and are living with HIV.
Not a fit: Patients who are not living with HIV or those who are already consistently adhering to their ART may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence among patients with HIV, leading to better health outcomes and reduced transmission rates.
How similar studies have performed: Previous research has shown that electronic adherence monitoring can improve medication adherence, suggesting that this approach may be effective.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DWORKIN, MARK S — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: DWORKIN, MARK S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.